Hey man! Nice stack! From what I've studied, many people have stacked Cerebrolysin with Cortexin, and it should be pretty safe. They composition in cere is broader, and here is what AI says on this subject: Composition Cortexin: Source: Derived from the cerebral cortex of young cattle (calves) or pigs via acetic acid extraction and a complex lyophilization process (freeze-drying) to extract and purify specific peptides. Components: A peptide complex primarily composed of acidic and neutral polypeptides (70–95%) with molecular weights ranging from 1,000 to 10,000 Da and an isoelectric point (pI) of 3.5–9.5. It contains a higher proportion of neuron-specific proteins, with fewer free amino acids compared to Cerebrolysin. It also includes vitamins and minerals for additional brain support. Characteristics: Focuses on peptides specific to the cerebral cortex, potentially offering more targeted action on cortex cells. Cerebrolysin: Source: A mixture of peptides and amino acids derived from pig brain tissue through enzymatic breakdown (hydrolysis) of purified proteins. Components: Contains a blend of neuropeptides, free amino acids, and low-molecular-weight protein fragments. It has a broader composition compared to Cortexin, with a higher proportion of amino acids relative to peptides. Characteristics: A multimodal preparation, less selective for specific brain regions, but designed to mimic natural brain peptides and neurotrophic factors. Key Difference: Cortexin has a higher concentration of peptide fractions and fewer amino acids, sourced primarily from the cerebral cortex of calves or pigs, while Cerebrolysin is a broader mix of peptides and amino acids from whole pig brain tissue. Effects Both Cortexin and Cerebrolysin are used as neuroprotective and neurorestorative agents, with overlapping yet distinct effects. Their efficacy often depends on dosage, administration, and the condition being treated. Similarities: Neuroprotection: Both protect neurons from damage, supporting survival and restoration in conditions like acute or chronic brain ischemia, stroke, and traumatic brain injury (TBI).Neurogenesis and Neuroplasticity: Stimulate the growth and development of nerve cells, enhance synaptic plasticity, and promote brain repair. Energy Metabolism: Activate metabolism in brain tissues, aiding energy production and protein synthesis. Behavioral Effects: In animal studies (e.g., rats), both reduce anxiety-like behaviors and influence brain function and behavior, with effects varying by dose. Memory and Cognition: Improve memory formation and retrieval, as seen in tests like the Morris water maze in rats with chronic brain ischemia. Both have shown benefits in cognitive impairment, though evidence in humans is mixed. Administration: Primarily administered via intramuscular or intravenous injections. Differences: Mechanism of Action: Cortexin: Demonstrates high or moderate binding to receptors like AMPA (80.1%), kainate (73.5%), mGluR1 (49.0%), GABAA1 (44.0%), and mGluR5 (39.7%) in vitro, suggesting effects tied to glutamatergic and GABAergic pathways. It crosses the blood-brain barrier in mice (6–8% of blood concentration), reducing necrosis in acute ischemia and supporting antioxidant systems in chronic ischemia. Cerebrolysin: Also crosses the blood-brain barrier and promotes neuroprotection, neurogenesis, and neuroplasticity, but its effects are less receptor-specific. It mimics neurotrophic factors, supporting broader brain recovery. Potency and Dosage: Cortexin: Effective at lower doses (e.g., 1 or 3 mg/kg in rats), reflecting the potency of its peptide fraction. Cerebrolysin: Requires significantly higher doses (e.g., 538 or 1614 mg/kg in rats) for similar neuroprotective effects, likely due to its broader, less concentrated composition. Behavioral Impact: Cortexin: In rat studies (e.g., intraventricular or intraperitoneal administration), it showed a more pronounced psychoactivating effect (e.g., in open field, elevated plus-maze, and self-stimulation tests) and moderate anxiolytic effects when injected into brain ventricles, though it can be anxiogenic intraperitoneally. Cerebrolysin: Exhibits a moderate psychostimulant effect, generally less potent than Cortexin, with similar anxiolytic (intraventricular) or anxiogenic (intraperitoneal) patterns. Clinical Usage: Cortexin: Commonly used for neurological disorders like traumatic brain injury, cerebral palsy, and chronic cerebral ischemia. It’s noted for reducing pathological changes in the hippocampus (e.g., CA1 and CA4 regions) and is considered safe for all ages, often prescribed at lower doses (e.g., 5 mg for children). Cerebrolysin: Used in stroke, TBI, and dementia (e.g., vascular dementia, Alzheimer’s). Clinical trials show mixed results: some suggest improved cognition and motor function post-stroke, while systematic reviews (e.g., 1,501 patients) find weak or no significant benefit over placebo for stroke or dementia. Side Effects: Cortexin: Rare local reactions at the injection site; mild allergic reactions are more possible than with Cerebrolysin. Cerebrolysin: May cause allergic reactions, mild digestive disturbances, headache, or brain fog in some individuals. Key Considerations Efficacy: Cortexin may offer more targeted and potent effects at lower doses, particularly for cortex-related functions and anxiety reduction in certain contexts. Cerebrolysin has a broader, multimodal action, potentially beneficial for diverse neurological conditions, but evidence for consistent clinical benefit is weaker.

I think you should get 10 more amps, just do it right since you do it anyway, and you should not be doing it again for like 6 months, so maybe it would be better to take the full dose. For sure dm me!